INSIGHTS ON DRUG DEVELOPMENT

• Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids

  Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.

• Eliminate Risk From Your Viral Vector Tech Transfers

  Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

• A Patented Process For Intermediates Useful For Upadacitinib

  Discover how innovative and safer synthetic strategies can streamline the manufacture of Upadacitinib while addressing the complexity and safety challenges inherent in its key intermediates.

• mRNA Vaccines And Therapeutics: Current Trends And Perspectives

  Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and explore how this technology is revolutionizing healthcare for the future and beyond.

• Building A Human-Centric Future For Biologics Development

  6/25/2026

  Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.

• MAPK Signaling Pathway

  4/7/2025

  Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development.

• NGS In GMP Manufacturing: Reducing Risk, Increasing Return

  1/29/2026

  Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.

• Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency

  9/25/2025

  Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

• Leveraging Early Insights To Accelerate The Oral Drug Development Cycle

  8/31/2026

  Consider how the following early development insights can help you navigate complex oral drug development and move your program forward with greater confidence.